Verici Dx plc
Status: Publicly traded
Direct answer
Verici Dx plc is publicly traded on LSE under the ticker VRCI.L.
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular...
Can you invest in Verici Dx plc?
Yes. Verici Dx plc trades publicly on LSE as VRCI.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Verici Dx plc
Detailed equity research is provided by MarketSnap.